McMillan Shakespeare Ltd

MMS: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|.p&LOCK|@J?LOCK|<@>s$x$

McMillan Shakespeare Earnings: Affected by Necessary Investments

McMillan Shakespeare's underlying NPATA for first-half fiscal 2025 declined 7% from first half fiscal 2024, affected by higher investments in customer acquisition and new technology. A recent large contract loss constrained revenue growth.

Sponsor Center